Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

A Bayesian hierarchical nonlinear model for assessing the association between genetic variation and drug cytotoxicity.

Fridley BL, Jenkins G, Schaid DJ, Wang L.

Stat Med. 2009 Sep 20;28(21):2709-22. doi: 10.1002/sim.3649.

2.

Use of cell lines in the investigation of pharmacogenetic loci.

Zhang W, Dolan ME.

Curr Pharm Des. 2009;15(32):3782-95. Review.

3.

Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies.

Shukla SJ, Dolan ME.

Pharmacogenomics. 2005 Apr;6(3):303-10. Review.

PMID:
16013961
4.
5.

Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.

Trent RJ, Cheong PL, Chua EW, Kennedy MA.

Pathology. 2013 Jun;45(4):357-70. doi: 10.1097/PAT.0b013e328360b66e. Review.

PMID:
23594690
6.

Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors.

Danesi R, Altavilla G, Giovannetti E, Rosell R.

Pharmacogenomics. 2009 Jan;10(1):69-80. doi: 10.2217/14622416.10.1.69. Review.

PMID:
19102717
7.

Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.

Albertini L, Siest G, Jeannesson E, Visvikis-Siest S.

Pharmacogenomics. 2011 May;12(5):681-91. doi: 10.2217/pgs.10.178. Review.

PMID:
21619430
8.

Pharmacogenetics and pharmacoepigenetics of gemcitabine.

Candelaria M, de la Cruz-Hernández E, Pérez-Cárdenas E, Trejo-Becerril C, Gutiérrez-Hernández O, Dueñas-González A.

Med Oncol. 2010 Dec;27(4):1133-43. doi: 10.1007/s12032-009-9349-y. Epub 2009 Nov 10. Review.

PMID:
19902390
9.

Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?

Ueno H, Kiyosawa K, Kaniwa N.

Br J Cancer. 2007 Jul 16;97(2):145-51. Epub 2007 Jun 26. Review.

10.

Identifying genomic and developmental causes of adverse drug reactions in children.

Becker ML, Leeder JS.

Pharmacogenomics. 2010 Nov;11(11):1591-602. doi: 10.2217/pgs.10.146. Review.

11.

Pharmacogenomics in schizophrenia: the quest for individualized therapy.

Basile VS, Masellis M, Potkin SG, Kennedy JL.

Hum Mol Genet. 2002 Oct 1;11(20):2517-30. Review.

12.

A conceptual framework for pharmacodynamic genome-wide association studies in pharmacogenomics.

Wu R, Tong C, Wang Z, Mauger D, Tantisira K, Szefler SJ, Chinchilli VM, Israel E.

Drug Discov Today. 2011 Oct;16(19-20):884-90. doi: 10.1016/j.drudis.2011.09.001. Epub 2011 Sep 6. Review.

13.

Impact of the 1000 genomes project on the next wave of pharmacogenomic discovery.

Zhang W, Dolan ME.

Pharmacogenomics. 2010 Feb;11(2):249-56. doi: 10.2217/pgs.09.173. Review.

14.

Expectations, validity, and reality in pharmacogenetics.

Limdi NA, Veenstra DL.

J Clin Epidemiol. 2010 Sep;63(9):960-9. doi: 10.1016/j.jclinepi.2009.09.006. Epub 2009 Dec 7. Review.

15.

Systems biology data analysis methodology in pharmacogenomics.

Rodin AS, Gogoshin G, Boerwinkle E.

Pharmacogenomics. 2011 Sep;12(9):1349-60. doi: 10.2217/pgs.11.76. Review.

16.

Pharmacogenomic approaches to individualizing chemotherapy for non-small-cell lung cancer: current status and new directions.

Gautschi O, Mack PC, Davies AM, Jablons DM, Rosell R, Gandara DR.

Clin Lung Cancer. 2008;9 Suppl 3:S129-38. doi: 10.3816/CLC.2008.s.019. Review.

PMID:
19419927
17.

Pharmacogenomics of adverse drug reactions: practical applications and perspectives.

Becquemont L.

Pharmacogenomics. 2009 Jun;10(6):961-9. doi: 10.2217/pgs.09.37. Review.

PMID:
19530963
18.

Gemcitabine and radiosensitization in human tumor cells.

Shewach DS, Lawrence TS.

Invest New Drugs. 1996;14(3):257-63. Review.

PMID:
8958180
19.

Pediatric perspective on pharmacogenomics.

Stevens A, De Leonibus C, Hanson D, Whatmore A, Murray P, Donn R, Meyer S, Chatelain P, Clayton P.

Pharmacogenomics. 2013 Nov;14(15):1889-905. doi: 10.2217/pgs.13.193. Review.

PMID:
24236488
20.

Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.

Hirsch FR, Helfrich B, Franklin WA, Varella-Garcia M, Chan DC, Bunn PA Jr.

Clin Breast Cancer. 2002 May;3 Suppl 1:12-6. Review.

PMID:
12057039
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk